Congenital heart diseaseCohort study

Outcomes of implantable cardioverter-defibrillator implantation in adults with congenitally corrected transposition of great arteries

Am Heart JPublished

  • Retrospective cohort study
  • Mayo Clinic (2003-2024)

Authors' conclusion

We observed a high rate of appropriate ICD shock, especially in the secondary prevention group. However, risk stratification of ICD implantation for primary prevention remains challenging. The absence of SCD (despite a high prevalence of all-cause mortality) suggest that ICD implantation may provide a survival benefit.

Study context

Population
Adults with congenitally corrected transposition of great arteries (cc-TGA) who underwent implantable cardioverter-defibrillator (ICD) implantationOf 278 patients, 87 (31%) underwent ICD implantation · primary prevention 67 · secondary prevention 20
Participants
87 adults
Exposure
primary versus secondary prevention
  • primary preventionn = 67
  • secondary preventionn = 20

Main finding

As reported in the abstract

Appropriate ICD shock

P = 0.006

Patients receiving appropriate ICD shock, overall
14 (16%)
Annual incidence of appropriate ICD shock, overall
3.7% per year

Observational data: associations, not effects.

Further findings

Inappropriate ICD shock

Patients receiving inappropriate ICD shock, overall
11 (13%)
Annual incidence, overall
3.5% per year
Similar between the 2 groups

Risk factors for appropriate ICD shock

Apart from ICD implantation for secondary prevention, none of the conventional risk factors were associated with an appropriate ICD shock

All-cause mortality and sudden cardiac death (SCD)

All-cause mortality
31%
None of the patients experienced SCD
  • exploratory outcome

Original publication

Outcomes of implantable cardioverter-defibrillator implantation in adults with congenitally corrected transposition of great arteries. Am Heart J. Published 21 March 2026. doi:10.1016/j.ahj.2026.107431

Summarised from the published abstract; every number is checked against it